Breynia retusa (Dennst.) Alston.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | B. patens Benth. |
| Family | Euphorbiaceae. |
| Habitat | The tropical Himalayas and Deccan peninsula. |
| Ayurvedic | Bahuprajaa, Kaamboji (doubtful synonym). |
| Folk | Kaali Kamboi (Gujarat). |
| Action | Used as a galactagogue (as a supporting drug in herbal compound formulations). Spasmogenic. |
| Taxonomic Cohort | Genus Breynia (1 documented species); Family Euphorbiaceae (50 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Breynia retusa (taxonomically cited with authority (Dennst.) Alston.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Euphorbiaceae (primary family classification: Euphorbiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. patens Benth, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: The tropical Himalayas and Deccan peninsula.
Across classical and vernacular Indian systems of medicine, Breynia retusa is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Bahuprajaa, Kaamboji (doubtful synonym); in regional Indian folk and vernacular ethnobotany as Kaali Kamboi (Gujarat). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Breynia retusa are: Used as a galactagogue (as a supporting drug in herbal compound formulations). Spasmogenic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
The therapeutic activity of Breynia retusa is grounded in its documented pharmacological actions (Used as a galactagogue (as a supporting drug in herbal compound formulations). Spasmogenic) and the characteristic secondary metabolite profile of the family Euphorbiaceae.

Botanical Reference 1: Breynia retusa — Botanical specimen

Botanical Reference 2: Breynia retusa — Botanical specimen

Botanical Reference 3: Breynia retusa — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Breynia retusa stands as a distinct representative of the genus Breynia. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Euphorbiaceae encompasses 50 documented medicinal species (2.76% of the 1,814-species flora). Other representative medicinal members of Euphorbiaceae include: Acalypha ciliata (Kuppi), Acalypha fruticosa (Birch-leaved Acalypha), Acalypha indica (Kuppi), Aleurities moluccana (Akshota), Baliospermum montanum (Danti). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 50 medicinal species of family Euphorbiaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Breynia retusa follow the plant-part modalities specified under its therapeutic action (Used as a galactagogue (as a supporting drug in herbal compound formulations). Spasmogenic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Breynia retusa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.